grant

Interleukin-17A promotes cigarette smoke-induced lung inflammation and damage [ 2012 - 2014 ]

Also known as: Role of interleukin-17A in cigarette smoke-induced lung inflammation

Funded by National Health and Medical Research Council
Managed by The University of Melbourne
Managed by University of Melbourne
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1027112]

Researchers: Prof Ross Vlahos (Principal investigator) ,  A/Pr Steven Bozinovski

Brief description Emphysema is a major global health problem and has been predicted to become the third largest cause of death in the world by 2020. Cigarette smoking is the major cause of emphysema and accounts for more than 95% of cases in industrialized countries. Cigarette smoke triggers cells in the lung to release substances which cause inflammation and "eat away" lung tissue. The aim of this project is to identify therapies to prevent and treat emphysema.

Funding Amount $AUD 650,590.93

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Cardiorespiratory Medicine and Haematology | Medical and Health Sciences | Respiratory Diseases | alveolar macrophages | animal model | cell biology | chronic obstructive pulmonary disease (COPD) | cigarette smoking | cytokines | inflammation | neutrophils | oxidative stress | smoking-related diseases |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA